Werewolf Therapeutics, Inc. (HOWL) vs Tevogen Inc. (TVGN)

Werewolf Therapeutics, Inc. and Tevogen Inc. are both Biotechnology companies. Werewolf Therapeutics, Inc. and Tevogen Inc. are of similar size ($51.1M and $47.7M). Tevogen Inc. has the higher net margin (0.00% vs −141.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Tevogen Inc. leads on 7 and Werewolf Therapeutics, Inc. on 4.

Valuation

Metric HOWL TVGN Biotechnology median
P/E n/m n/m 7.88
P/S 1.91 n/m 11.47
P/B 2.86 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 1.90 n/m 10.73
Earnings yield (76.04%) (85.53%) (28.84%)
Free cash flow yield (64.04%) (41.91%) (23.03%)

Profitability

Metric HOWL TVGN Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (128.18%) 0.00% 0.00%
Net margin (141.94%) 0.00% 0.00%
Free cash flow margin (122.51%) 0.00% 0.00%
Return on equity (119.86%) 123.10% (57.72%)
Return on assets (59.31%) (492.20%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric HOWL TVGN Biotechnology median
Revenue growth (TTM) (5.21%) — 5.64%
EPS growth (last fiscal year) 18.40% (72.66%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric HOWL TVGN Biotechnology median
Debt to equity 0.00 (0.72) 0.00
Current ratio 2.91 0.33 4.73
Net debt to EBITDA 0.97 (0.15) 0.96

Dividend

Metric HOWL TVGN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric HOWL TVGN Biotechnology median
Market cap 47.68m 51.12m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack